Insight Molecular Diagnostics (IMDX) Revenue Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.49% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 5.54% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 9.66% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 38.82% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 9.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 4.48% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.21% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -98.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.50% |
| Dec 31, 2025 | -23.35% |
| Sep 30, 2025 | 126.09% |
| Jun 30, 2025 | 398.08% |
| Mar 31, 2025 | 1,114.77% |
| Dec 31, 2024 | 373.25% |
| Sep 30, 2024 | -73.19% |
| Jun 30, 2024 | -77.54% |
| Mar 31, 2024 | -40.74% |
| Dec 31, 2023 | -92.13% |
| Sep 30, 2023 | 540.30% |
| Jun 30, 2023 | 95.36% |
| Mar 31, 2023 | -71.55% |
| Dec 31, 2022 | 11.15% |
| Sep 30, 2022 | -93.19% |
| Jun 30, 2022 | -88.33% |
| Mar 31, 2022 | -7.12% |
| Dec 31, 2021 | 613.52% |
| Sep 30, 2021 | 77.30% |
| Jun 30, 2021 | 1,319.58% |